Earnings Central: Bharti Airtel Beats Street Estimates, Morepen Labs Hits Upper Circuit, Greaves Cotton Sells Off
Key Takeaways
- •Bharti Airtel exceeded Street estimates, supported by strong subscriber additions across its India and Africa operations in a competitive three-player domestic telecom market.
- •Morepen Laboratories shares hit the upper circuit after a record quarter driven by its CDMO strategy, which is benefiting from global pharmaceutical companies diversifying supply chains away from China.
- •Greaves Cotton experienced a sharp share price decline as profit and margin figures fell even though revenue rose, highlighting margin pressure from volatile input costs.
- •Pidilite Industries serves as a bellwether for construction and infrastructure demand, while Marico's results offer a window into uneven rural consumption trends.
- •Additional companies reporting on the day included Hexacom, Godreq Properties, Aarti Drugs, and Jindal Stainless, with management commentary addressing pricing trends and capacity expansion plans.

Tuesday's earnings season delivered a mixed bag of results across major Indian companies, with Bharti Airtel, Hexacom, Pidilite Industries, Morepen Laboratories, Greaves Cotton, and Marico all reporting their latest quarterly figures.
Heavyweights Set the Tone
Bharti Airtel stood out among the large-cap reporters, beating Street expectations on the back of strong subscriber growth. The telecom major's performance underscored robust demand across its India and Africa operations. Airtel competes in an effectively three-player domestic market alongside Reliance Jio and Vodafone Idea, and its results come as the industry continues to monetize 5G services rolled out since late 2022, with investors closely tracking ARPU (Average Revenue Per User) as a key indicator of pricing power.
Marico and Pidilite Industries also reported their quarterly results, adding to the picture of corporate India's performance in the latest period. Pidilite, best known for its Fevicol adhesive brand, serves as a bellwether for construction and infrastructure demand, while Marico's consumer staples portfolio offers a read on rural consumption trends that have been uneven across recent quarters.
Standout Performer
Morepen Laboratories emerged as a clear standout, with its stock hitting the upper circuit after what the company described as a record quarter. The pharmaceutical firm's earnings were driven by its ongoing CDMO (Contract Development and Manufacturing Organization) scale-up strategy. India's CDMO sector has been a key beneficiary of global pharmaceutical companies diversifying supply chains away from China under "China Plus One" strategies, positioning Indian manufacturers for sustained contract manufacturing growth.
Notable Miss
Greaves Cotton experienced a sharp selloff following its quarterly results, as investors reacted to the company's financial performance. The engineering company's profit and margin figures fell even as revenue rose, prompting a significant share price decline. The margin compression reflects a broader challenge for Indian manufacturers navigating volatile input costs, even as Greaves Cotton continues its strategic pivot toward electric mobility and clean energy solutions.
Other Results
Other companies reporting on the day included Hexacom, Godrej Properties, Aarti Drugs, and Jindal Stainless, among others. Management commentary across the batch of results provided insight into pricing trends, capacity expansion plans, and forward-looking guidance for the coming fiscal periods.
Source: CNBC-TV18 Markets